Previous 10 | Next 10 |
Product Revenue up 85% over Q3 2018 Reiterates Full-Year Revenue Guidance of $9.5-10 Million SOUTH ORANGE, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification produ...
SOUTH ORANGE, NJ, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will file its third qua...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Market Perform rating and $44 (5% upside) price target at Oppenheimer. More news on: ACADIA Pharmaceuticals Inc., Nektar Therapeutics, Neovasc Inc., Healthcare stocks news, Stocks on the move, , Read more ...
SOUTH ORANGE, NJ - ( NewMediaWire ) - October 14, 2019 - Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, will visit the Nasdaq MarketSite in Times Square. ...
Anticipates $3.1 Million Product Revenue, 85% Growth Over 2018 Increases Full-Year Revenue Guidance to $9.5-10 Million SOUTH ORANGE, NJ, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells hi...
SOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming...
SOUTH ORANGE, NJ, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that its common shares have been...
Nephros, Inc (NEPH) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Kirin Smith – President-PCG Advisory Daron Evans – Chief Executive Officer Andy Astor – Chief Financial Officer and Chief Operating Officer Conference Call ...
Nephros ( OTCQB:NEPH ): Q2 GAAP EPS of -$0.14 beats by $0.04 . More news on: Nephros, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SOUTH ORANGE, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced financial results for the three months ended June 3...
News, Short Squeeze, Breakout and More Instantly...
First-Quarter Net Revenue of $3.5 Million; Technology Advancements and Microplastics Capabilities on the Horizon SOUTH ORANGE, NJ - ( NewMediaWire ) - May 09, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and co...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
SOUTH ORANGE, NJ - ( NewMediaWire ) - May 02, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its first quarter financial results on Thursday, May 09, 2024 after ...